Clinical Trial Update: Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Revolution Medicines is conducting a Phase 1/2 clinical trial of RAS(ON) inhibitors in gastrointestinal solid tumors, including colorectal cancer and pancreatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastrointestinal Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• RAS(ON) inhibitors

Snippet

Sponsor: Revolution Medicines, Inc. | Conditions: Colorectal Cancer, CRC | Phase 1, Phase 2 | Status: RECRUITING